Antonio Tito Fojo

Credentials: · · · · · ·

History

Multidrug resistance in cancer: role of ATP-dependent transporters
Review · Nature reviews. Cancer · 2002 · 4,485 citations
Tumour stem cells and drug resistance
Review · Nature reviews. Cancer · 2005 · 2,987 citations
Expression of a multidrug-resistance gene in human tumors and tissues
Proceedings of the National Academy of Sciences of the United States of America · 1987 · First of 6 authors · 1,623 citations

Creating Precision in Metastatic Hormone Sensitive Prostate Cancer: Using Tumor Genetics and Patient Characteristics to Predict Outcomes and Improve Treatment Selection
Department of Veterans Affairs · I01
PI · St. Louis Va Medical Center
2025–2029
Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $741.2K · Columbia University Health Sciences
1997–2025
NIH Hematology Oncology Fellowship Program
National Cancer Institute · ZIE
Contact PI · $31M · Division of Basic Sciences - Nci
Medical Oncology Fellowship Program
National Cancer Institute · Z01
Contact PI · $13.6M · Division of Basic Sciences - Nci

Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer
Principal investigator · Withdrawn · Phase 2
Antonio Fojo
2019–2021
LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)
Principal investigator · Active not recruiting · Phase 2
Antonio Fojo
2019–2027
Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma
Principal investigator · Active not recruiting · Phase 2
Columbia University
2019–2027
Entinostat Neuroendocrine (NE) Tumor
Principal investigator · Terminated · Phase 2
Antonio Fojo
2017–2021